Cilostazol

Key Product Details

Product Description

Cilostazol is a potent phosphodiesterase III A (PDE3A) inhibitor (IC₅₀ = 0.2 μM) and inhibitor of adenosine uptake. Has antimitogenic, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo.

Product Specifications for Cilostazol

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Solubility

Preparing Stock Solutions for Cilostazol

The following data is based on the product molecular weight 369.47.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:

1 Recalculate

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.5 mM	5.41 mL	27.07 mL	54.13 mL
2.5 mM	1.08 mL	5.41 mL	10.83 mL
5 mM	0.54 mL	2.71 mL	5.41 mL
25 mM	0.11 mL	0.54 mL	1.08 mL

Calculators

Background References

References are publications that support the biological activity of the product. See our Citations tab to view 11 publications citing the usage of this product.

• Shintani General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: effects on the central nervous system. Arzneimittelforschung 1985 PMID: 4074429
• Shintani General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: effects on the peripheral organs. Arzneimittelforschung 1985 PMID: 3000392
• Schror The pharmacology of cilos. Diabetes Obes.Metab. 2002 PMID: 12180353

Product Documents for Cilostazol